sc 58125 has been researched along with leupeptins in 1 studies
| Studies (sc 58125) | Trials (sc 58125) | Recent Studies (post-2010) (sc 58125) | Studies (leupeptins) | Trials (leupeptins) | Recent Studies (post-2010) (leupeptins) |
|---|---|---|---|---|---|
| 93 | 0 | 15 | 3,891 | 4 | 1,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallois, C; Habib, A; Lotersztajn, S; Maclouf, J; Mallat, A; Moulin, S; Tao, J | 1 |
1 other study(ies) available for sc 58125 and leupeptins
| Article | Year |
|---|---|
Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.
Topics: Adipocytes; Antineoplastic Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dimerization; DNA-Binding Proteins; Endothelin-1; Fibroblasts; Humans; I-kappa B Proteins; Isoenzymes; Leupeptins; Liver; Membrane Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Receptor, Endothelin B; Receptors, Endothelin; Sodium Salicylate; Tumor Necrosis Factor-alpha; Up-Regulation; Viper Venoms | 1998 |